The Impact of UGT1A1 Genetic Variability on Enzyme Expression in Liver PathologyUGT1A1基因多态性对肝脏病理中酶表达的影响GenesIF2.82026-05-220OA
The reference liver-CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotypePHARMACOLOGICAL REPORTSIF3.82021-11-064OAAI
Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver PathologyPHARMACEUTICSIF5.52021-08-2512OAAI
Hepatic drug-metabolizing enzymes and drug transporters in Wilson's disease patients with liver failurePHARMACOLOGICAL REPORTSIF3.82021-06-113OAAI
Protein Abundance of Hepatic Drug Transporters in Patients With Different Forms of Liver DamageCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52019-12-1748PREAI
The reference liver - ABC and SLC drug transporters in healthy donor and metastatic liversPHARMACOLOGICAL REPORTSIF3.82019-08-0117PREAI
In vitro and in vivo evaluation of sandwich-like mesoporous silica nanoflakes as promising anticancer drug delivery systemINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22016-06-019PREAI
Mesoporous silica nanoflakes - Biocompatibility, cellular uptake and drug transportPHARMACOLOGICAL REPORTSIF3.82015-09-010PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向